What differs in practice is starting volume and titration speed, since women in these programs often start at a lower body weight and report more injection-site sensitivity at the top of the range
Operational changes are not easily or quickly implemented, but GLP-1 usage is not going away, and only shows signs of growing
These may include nausea, vomiting, diarrhea, and stomach pain
Ocular Very common (10% or more): Diabetic retinopathy (up to 20.1%) Common (1% to 10%): Retinal disorders, diabetic retinopathy complications Uncommon (0.1% to 1%): Nonproliferative retinopathy Very rare (less than 0.01%): Nonarteritic anterior ischemic optic neuropathy (NAION) Diabetic retinopathy complications included need for retinal photocoagulation, need for treatment with intravitreal agents, vitreous hemorrhage, and onset of diabetes-related blindness
Do Benefits Last After Stopping the Medication